The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review

Feb 12, 2026Brain research bulletin

Gut bacteria products linked to Parkinson's disease

AI simplified

Gut-Brain Axis on OpenScience ↗PubMed ↗DOI ↗

Abstract

Emerging evidence suggests that Parkinson's disease is associated with disturbances in gut bacteria and their metabolites.

Bacterial products from tryptophan, particularly indole compounds, may link intestinal imbalances to neurodegeneration.
There is a reduction in beneficial bacteria that produce indoles and an increase in harmful bacteria that convert tryptophan into toxic substances.
This shift could disrupt the function of the epithelial and blood-brain barriers and increase inflammation and oxidative stress in the brain.
Beneficial metabolites like indole-3-propionic acid and indole-3-acetic acid may help protect against neuroinflammation and support barrier stability.
Conversely, harmful metabolites such as indoxyl sulfate could contribute to neuroinflammation and neuron loss.
These findings indicate a potential metabolic imbalance between protective and harmful indoles in Parkinson's disease.

AI simplified

Emerging evidence suggests that Parkinson's disease (PD) extends beyond the brain and involves early disturbances along the gut-brain axis. Among the metabolites shaping this communication, bacterial products derived from tryptophan, particularly indole compounds, are gaining attention as key biochemical links between intestinal dysbiosis and neurodegeneration. Multi-omics studies consistently show a reduction in commensal bacteria capable of producing beneficial indoles and an enrichment of Enterobacteriaceae that redirect tryptophan catabolism toward toxic intermediates. This shift disrupts epithelial and blood-brain barrier function and amplifies inflammatory and oxidative stress pathways within the central nervous system. Protective metabolites such as indole-3-propionic acid (IPA), indole-3-acetic acid (IAA), indole-3-lactic acid (ILA), and indole-3-carbinol (I3C) exert antioxidant, barrier-stabilizing, and anti-inflammatory effects through receptors including the aryl hydrocarbon and pregnane X receptors. Conversely, uremic indoles such as indoxyl sulfate (IS) and p-cresyl sulfate (pCS) activate microglia and astrocytes, promote α-synuclein aggregation, and accelerate dopaminergic neuron loss. Together, these findings support a view of PD as a metabolic imbalance between neuroprotective and neurotoxic indoles. Understanding how microbial and host pathways regulate this balance may open opportunities for early diagnosis and targeted interventions that integrate metabolism, immunity, and neuroprotection.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the gut-brain axis brief